HeyTea has filed permits to open a compact 1,500‑sq‑ft tea house at 180 Pleasant Street in Malden. Signage is underway but an opening date remains TBA.

A 68-year-old man was found unresponsive after a neighbor dispute at a Middleborough multi-family home; one person was arrested and the Plymouth County DA is investigating.

A reworked clean-energy bill heads to the Massachusetts House Thursday, promising near-term bill relief while trimming some clean-energy programs. Supporters call it affordability; advocates warn of backsliding.

Boston officials confirm H5 avian influenza in birds in the Emerald Necklace; risk to people is low but residents and pet owners should avoid sick or dead birds and report sightings.

A Boston judge ruled DHS's third‑country deportation policy unlawful but delayed enforcement for 15 days while appeals proceed. The decision raises fresh legal and political questions.

An Upton man faces multiple charges after police say he threatened motorists near downtown Milford and exposed himself during booking.

Defense says the man charged in the Mattapan killing can’t review surveillance and body‑cam footage while held in Middleton. A transfer hearing is set for Thursday.

Springfield detectives say a mid‑February probe led to three arrests and the seizure of more than 100 grams of cocaine, cash and an illegal firearm.

The state’s high court denied a bid to reopen Dennis Bateman’s 2007 convictions in the 2005 Deerfield Sunoco killings, keeping his life sentences intact.

Ama at The Atlas brings Comfort Kitchen’s founders to Allston with caregiver‑inspired soups, momos and global plates — and a pledge to a local family nonprofit.

New York asked FERC to dismiss Williams' bid to reissue the Constitution Pipeline certificate, citing a Second Circuit vacatur and asserting state water‑quality authority.

MassDOT and Amtrak plan new tracks, high‑level platforms and a four‑track layover yard at Springfield Union Station to clear a rail bottleneck and prepare for expanded Amtrak routes.

Novo Nordisk partnered with Boston startup Vivtex to develop next‑generation oral obesity and diabetes pills. The deal could deliver up to $2.1 billion to the local biotech.